Event Brief
Feb 27, 2026 at 10:04 AM ET
New Oral Pill Shows 8% Weight Loss in Trials
By The BriefBrief
Eli Lilly’s orforglipron outperforms semaglutide with 8% weight loss in trials.
WHO: Eli Lilly
WHAT: New oral weight-loss pill orforglipron
WHEN: Feb 27, 2026 at 9:24 AM ET
WHERE: Location not specified
WHY: To provide a more effective weight-loss treatment
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Amazon faces months of repairs after drone strikes
Amazon
May 1, 2026 at 3:23 PM ET
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21447 of 21447
Same format. Every time.
Continue reading — sign in or create a free account with
